6533b855fe1ef96bd12aff1c
RESEARCH PRODUCT
In-use physicochemical and microbiological stability of biological parenteral products
Jonas FastMichael AdlerIrene KrämerWilliam J. GalushHanns-christian MahlerJamie MooreUlla GrauschopfMargaret Speed RicciUlrike AltenburgerAnkit R. PatelMichelle FrazierMary E.m. CromwellPierre Goldbachsubject
PharmacologyBiological ProductsBacteriabusiness.industryChemistry PharmaceuticalDrug CompoundingHealth PolicyProteinsBiotechnologyPharmaceutical SolutionsDrug StabilityHumansInfusions ParenteralBusinessBiochemical engineeringProduct (category theory)Drug ContaminationDrug PackagingBiotechnology industrydescription
Pharmaceutical scientists in the biotechnology industry have traditionally focused on achieving acceptable shelf lives of drug products in their original, unopened product unit configuration (e.g., two years stored at 2–8 °C). However, it is now clear that stability considerations extend beyond
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-03-01 | American Journal of Health-System Pharmacy |